3-propylamino-5-hydroxychroman has been researched along with quipazine in 1 studies
Studies (3-propylamino-5-hydroxychroman) | Trials (3-propylamino-5-hydroxychroman) | Recent Studies (post-2010) (3-propylamino-5-hydroxychroman) | Studies (quipazine) | Trials (quipazine) | Recent Studies (post-2010) (quipazine) |
---|---|---|---|---|---|
8 | 0 | 0 | 658 | 0 | 41 |
Protein | Taxonomy | 3-propylamino-5-hydroxychroman (IC50) | quipazine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 3E | Homo sapiens (human) | 0.0004 | |
5-hydroxytryptamine receptor 3B | Homo sapiens (human) | 0.0004 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 1.4454 | |
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.47 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 1.4 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.7 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0617 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 3.7297 | |
5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.0035 | |
5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 0.0004 | |
5-hydroxytryptamine receptor 1D | Sus scrofa (pig) | 3.7153 | |
Adenylate cyclase type 5 | Rattus norvegicus (Norway rat) | 1.4454 | |
5-hydroxytryptamine receptor 3D | Homo sapiens (human) | 0.0004 | |
5-hydroxytryptamine receptor 2A | Bos taurus (cattle) | 3.4674 | |
5-hydroxytryptamine receptor 3C | Homo sapiens (human) | 0.0004 | |
5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.0035 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kostowski, W; Pałejko, W; Płaźnik, A; Stefański, R | 1 |
1 other study(ies) available for 3-propylamino-5-hydroxychroman and quipazine
Article | Year |
---|---|
Serotonergic mechanisms in the nucleus accumbens affected by chronic desipramine treatment.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Buspirone; Chromans; Desipramine; Dose-Response Relationship, Drug; Methysergide; Microinjections; Nucleus Accumbens; Pindolol; Quipazine; Rats; Serotonin; Serotonin Antagonists; Tetrahydronaphthalenes | 1991 |